CNBC Daily Open: Tech sell-off? Investors could just be taking profit and enjoying the summer

CNBC Daily Open: Tech sell-off? Investors could just be taking profit and enjoying the summer


A Palantir sign at the World Economic Forum annual meeting in Davos, Switzerland, on May 22, 2022.

Fabrice Coffrini | Afp | Getty Images

If you have any U.S. technology stocks in your portfolio (and let’s face it, who doesn’t?), you might want to look away.

For the second day in a row, tech stocks dragged markets lower, with the Nasdaq Composite slipping 0.67%. Juggernauts such as Apple, Amazon and Alphabet were more meh-nificent than magnificent, falling more than 1%.

Palantir — the standout S&P 500 stock, having more than doubled so far this year — had its sixth consecutive day in the red and lost its place among a ranking of the 20 most valuable U.S. companies.

While Palantir’s slide was partly triggered by a report from short seller Andrew Left’s Citron Research, which called the company “detached from fundamentals and analysis,” there was no single trigger for the broader pullback.

Investors could have been spooked by OpenAI CEO Sam Altman’s caution about an AI bubble forming, although some analysts dispute that assertion. “In our view the tech bull cycle will be well intact at least for another 2-3 years,” said Wall Street tech bull Dan Ives.

Or it could be something benign, like traders locking in profits. “Tech stocks,” said Carol Schleif, chief market strategist at BMO Private Wealth, “have had an incredibly strong run – with some up over 80% since the early April lows.”

Summer, after all, is far from over. Some investors might have just wanted to cash out for another round of margaritas.

What you need to know today

And finally…

U.S. President Donald Trump and Russian President Vladimir Putin arrive for a press conference at Joint Base Elmendorf-Richardson on Aug. 15, 2025 in Anchorage, Alaska.

Andrew Harnik | Getty Images

Red carpet for Putin, trade relief for China, penalties on India: Inside Trump’s peculiar policy playbook

U.S. President Donald Trump is pursuing an unusual strategy — courting Russian President Vladimir Putin, holding fire on Beijing, all the while turning the screws on India.

Despite India being one of the earliest nations to engage in negotiations with the Trump administration, there is still no sign of it sealing a deal with America. New Delhi is now also staring at a secondary tariff of 25% or a “penalty” for its purchases of Russian oil that is set to come into effect later this month.

— Anniek Bao



Source

EU and South American bloc Mercosur sign trade deal after 25 years of negotiations
World

EU and South American bloc Mercosur sign trade deal after 25 years of negotiations

European Council President Antonio Costa, European Commission President Ursula von der Leyen, Paraguay’s President Santiago Pena and Argentina’s President Javier Milei during the signing ceremony of a free trade agreement between the European Union and the South American bloc Mercosur, ending more than 25 years of negotiations, in Asuncion, Paraguay, on Jan. 17, 2026. Cesar […]

Read More
Musk seeks up to 4 billion from OpenAI and Microsoft in ‘wrongful gains’
World

Musk seeks up to $134 billion from OpenAI and Microsoft in ‘wrongful gains’

Elon Musk, chief executive officer of Tesla Inc., during the US-Saudi Investment Forum at the Kennedy Center in Washington, DC, US, on Wednesday, Nov. 19, 2025. Bloomberg | Bloomberg | Getty Images Elon Musk is seeking up to $134 billion from OpenAI and Microsoft, saying he deserves the “wrongful gains” that they received from his […]

Read More
Activist Irenic takes a stake in Integer. Here’s what could be next for the company
World

Activist Irenic takes a stake in Integer. Here’s what could be next for the company

Timon Schneider | SOPA Images | AP Company: Integer Holdings Corp (ITGR) Business: Integer Holdings Corporation is a medical device contract development and manufacturing company. Its brands include Greatbatch Medical and Lake Region Medical. The company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural […]

Read More